NetraMark

Toronto, Canada

NetraMark is an AI and pharma-tech company, has developed proprietary solutions for pharmaceutical and biotechnology companies.

$2.5M raised

Jan 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NetraMark raised?

NetraMark has raised $2.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2026.

Who are NetraMark's investors?

NetraMark's investors include Creative Destruction Lab.

Where is NetraMark headquartered?

NetraMark is headquartered in Toronto, Canada.

What does NetraMark do?

NetraMark is an AI and pharma-tech company, has developed proprietary solutions for pharmaceutical and biotechnology companies.

What stage is NetraMark at?

NetraMark is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 13, 2026.

MLA

"NetraMark — Funding & Investors." VCBacked, January 13, 2026, https://www.vcbacked.co/company/netramark. Accessed July 2, 2026.

APA

VCBacked. (2026). NetraMark — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/netramark

Wikipedia (cite web)

{{cite web |title=NetraMark — Funding & Investors |url=https://www.vcbacked.co/company/netramark |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 13, 2026.